CSS
OMGA

Cubist Systematic Strategies’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Cubist Systematic Strategies’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,617
Closed -$23.6K – 3671
2024
Q4 		$23.6K Hold
31,617
– – ﹤0.01% 2831
2024
Q3 		$38.6K Hold
31,617
– – ﹤0.01% 2780
2024
Q2 		$65.4K Buy
31,617
+13,873
+78% +$32.7K ﹤0.01% 2682
2024
Q1 		$64.8K Buy
+17,744
New +$68K ﹤0.01% 3337
2023
Q2 		– Sell
-10,007
Closed -$60.3K – 4439
2023
Q1 		$60.3K Buy
10,007
+6,267
+168% +$43.6K ﹤0.01% 3534
2022
Q4 		$21.4K Sell
3,740
-771
-17% -$4.33K ﹤0.01% 3987
2022
Q3 		$24K Sell
4,511
-3,781
-46% -$19.2K ﹤0.01% 4223
2022
Q2 		$32K Sell
8,292
-3,555
-30% -$13.2K ﹤0.01% 4166
2022
Q1 		$74K Buy
11,847
+11,766
+14,526% +$120K ﹤0.01% 3305
2021
Q4 		$1K Sell
81
-2,338
-97% -$44.5K ﹤0.01% 3427
2021
Q3 		$46K Buy
+2,419
New +$46.4K ﹤0.01% 2843

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cubist Systematic Strategies's OMGA Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 31,617 shares — an estimated $23.6K sold.

Cubist Systematic Strategies first reported a position in OMGA in Q3 2021 and held it in 11 quarters. The position peaked at $74K in Q1 2022. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 31,617 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $23.6K.
  • Cubist Systematic Strategies first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Cubist Systematic Strategies's Omega Therapeutics, Inc. Common Stock position peaked at $74K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.